These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 17284370)

  • 1. Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14).
    Guglielmelli T; Giugliano E; Cappia S; Papotti M; Saglio G
    Cancer Genet Cytogenet; 2007 Feb; 173(1):51-6. PubMed ID: 17284370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
    Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
    Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations.
    Agnelli L; Bicciato S; Mattioli M; Fabris S; Intini D; Verdelli D; Baldini L; Morabito F; Callea V; Lombardi L; Neri A
    J Clin Oncol; 2005 Oct; 23(29):7296-306. PubMed ID: 16129847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells.
    Katayama Y; Sakai A; Okikawa Y; Oue N; Asaoku H; Sasaki A; Imanaka F; Tsujimoto T; Takimoto Y; Masuda R; Nakaju N; Otsuki T; Yasui W; Kimura A
    Int J Oncol; 2004 Sep; 25(3):579-95. PubMed ID: 15289859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
    Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
    Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival.
    Cook JR; Hsi ED; Worley S; Tubbs RR; Hussein M
    Am J Clin Pathol; 2006 Apr; 125(4):615-24. PubMed ID: 16627271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal translocations t(4;14), t(11;14) and proliferation rate stratify patients with mature plasma cell myelomas into groups with different survival probabilities: a molecular epidemiologic study on tissue microarrays.
    Tinguely M; Jenni B; Reineke T; Korol D; Kofler A; Rousson V; Dommann-Scherrer C; Maurer R; Moch H; Probst-Hensch NM
    Am J Surg Pathol; 2007 May; 31(5):690-6. PubMed ID: 17460451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
    Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
    Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction.
    Vieira L; Martinho A; Antunes O; Silva E; Ambrósio AP; Geraldes MC; Nascimento R; Silva C; Pereira JM; Júnior EC; Jordan P
    Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
    Glassford J; Rabin N; Lam EW; Yong KL
    Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
    Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
    Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
    Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1.
    Jhang JS; Narayan G; Murty VV; Mansukhani MM
    Cancer Genet Cytogenet; 2004 Mar; 149(2):114-9. PubMed ID: 15036886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 positive multiple myeloma: predominance of the short, 3'UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions.
    Slotta-Huspenina J; Koch I; Richter M; Bink K; Kremer M; Specht K; Krugmann J; Quintanilla-Martinez L; Fend F
    Leuk Res; 2008 Jan; 32(1):79-88. PubMed ID: 17629555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocation.
    Pruneri G; Fabris S; Fasani R; Del Curto B; Capella C; Pozzi B; Motta T; Andreola S; Ferreri AJ; Ponzoni M; Viale G; Neri A
    J Pathol; 2003 Aug; 200(5):596-601. PubMed ID: 12898595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected.
    Stefancikova L; Moulis M; Fabian P; Falkova I; Vasova I; Kren L; Macak J; Smardova J
    J Clin Pathol; 2009 Oct; 62(10):948-50. PubMed ID: 19783727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation.
    Seto M; Yamamoto K; Iida S; Akao Y; Utsumi KR; Kubonishi I; Miyoshi I; Ohtsuki T; Yawata Y; Namba M
    Oncogene; 1992 Jul; 7(7):1401-6. PubMed ID: 1535701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.